流通市值:27.27亿 | 总市值:27.27亿 | ||
流通股本:2.25亿 | 总股本:2.25亿 |
报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 1,172,633,875.3 | 1,180,150,636.34 | 1,285,478,757.85 | 1,243,750,455.46 |
结算备付金 | 0 | 0 | 0 | 0 |
拆出资金 | 0 | 0 | 0 | 0 |
衍生金融资产 | 0 | 0 | 0 | 0 |
应收票据及应收账款 | 64,520,707.81 | 64,421,048.05 | 70,476,408.52 | 75,878,717.59 |
其中:应收票据 | 0 | 0 | 0 | 0 |
应收账款 | 64,520,707.81 | 64,421,048.05 | 70,476,408.52 | 75,878,717.59 |
应收款项融资 | 0 | 0 | 0 | 0 |
预付款项 | 26,995,964.91 | 16,136,523.89 | 17,501,799.03 | 18,223,212.36 |
应收保费 | 0 | 0 | 0 | 0 |
应收分保账款 | 0 | 0 | 0 | 0 |
应收分保合同准备金 | 0 | 0 | 0 | 0 |
其他应收款合计 | 9,517,734.79 | 14,222,312.67 | 27,221,874.74 | 43,046,727.32 |
其中:应收利息 | 0 | 0 | 0 | 0 |
应收股利 | 0 | 0 | 0 | 0 |
买入返售金融资产 | 0 | 0 | 0 | 0 |
存货 | 122,080,581.93 | 141,772,568.05 | 149,425,050.68 | 166,103,719.96 |
合同资产 | 0 | 0 | 0 | 0 |
一年内到期的非流动资产 | 0 | 0 | 0 | 0 |
其他流动资产 | 23,502,633.32 | 16,118,534.11 | 8,112,835.35 | 8,278,594.68 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 1,484,481,080.06 | 1,483,451,205.11 | 1,577,841,168.94 | 1,555,281,427.37 |
非流动资产: | ||||
发放委托贷款及垫款 | 0 | 0 | 0 | 0 |
债权投资 | 0 | 0 | 0 | 0 |
其他债权投资 | 0 | 0 | 0 | 0 |
长期应收款 | 0 | 0 | 0 | 0 |
长期股权投资 | 216,875,287.27 | 217,759,655.83 | 219,524,248.59 | 220,916,348.81 |
其他权益工具投资 | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 |
其他非流动金融资产 | 203,033,048.39 | 203,033,048.39 | 203,033,048.39 | 203,033,048.39 |
投资性房地产 | 0 | 0 | 0 | 0 |
固定资产 | 72,727,901.39 | 74,110,140.81 | 75,606,936.87 | 68,010,982.52 |
在建工程 | 144,593,550.62 | 97,087,512.03 | 53,960,218.88 | 30,528,476.87 |
生产性生物资产 | 0 | 0 | 0 | 0 |
油气资产 | 0 | 0 | 0 | 0 |
使用权资产 | 1,356,846.06 | 1,850,034.84 | 2,343,223.62 | 2,836,412.4 |
无形资产 | 80,084,207.36 | 80,805,515.66 | 81,574,917.5 | 82,297,667.58 |
开发支出 | 0 | 0 | 0 | 0 |
商誉 | 0 | 0 | 0 | 0 |
长期待摊费用 | 510,794.94 | 585,061.02 | 670,792.31 | 752,835.49 |
递延所得税资产 | 6,218,496.51 | 6,294,177.59 | 6,638,508.05 | 6,655,485.7 |
其他非流动资产 | 2,521,048.99 | 3,491,090.19 | 4,181,102.19 | 4,130,146.88 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 733,921,181.53 | 691,016,236.36 | 653,532,996.4 | 625,161,404.64 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 2,218,402,261.59 | 2,174,467,441.47 | 2,231,374,165.34 | 2,180,442,832.01 |
流动负债: | ||||
短期借款 | 0 | 0 | 0 | 0 |
向中央银行借款 | 0 | 0 | 0 | 0 |
吸收存款及同业存放 | 0 | 0 | 0 | 0 |
拆入资金 | 0 | 0 | 0 | 0 |
交易性金融负债 | 0 | 0 | 0 | 0 |
衍生金融负债 | 0 | 0 | 0 | 0 |
应付票据及应付账款 | 114,399,591.67 | 100,019,342.33 | 99,449,432.8 | 84,331,121.18 |
其中:应付票据 | 0 | 0 | 0 | 0 |
应付账款 | 114,399,591.67 | 100,019,342.33 | 99,449,432.8 | 84,331,121.18 |
预收款项 | 0 | 0 | 0 | 0 |
合同负债 | 89,205,260.3 | 70,265,243.95 | 81,280,241.21 | 50,405,448.86 |
卖出回购金融资产款 | 0 | 0 | 0 | 0 |
应付手续费及佣金 | 0 | 0 | 0 | 0 |
应付职工薪酬 | 7,464,255.13 | 7,737,860.75 | 7,734,876.41 | 18,228,650.07 |
应交税费 | 10,855,116.22 | 8,868,749.87 | 14,771,349.67 | 9,988,392.55 |
其他应付款合计 | 19,321,705.73 | 29,545,873.24 | 25,908,415.13 | 20,593,885.14 |
其中:应付利息 | 0 | 0 | 0 | 0 |
应付股利 | 0 | 8,760,284.92 | 0 | 0 |
应付分保账款 | 0 | 0 | 0 | 0 |
保险合同准备金 | 0 | 0 | 0 | 0 |
代理买卖证券款 | 0 | 0 | 0 | 0 |
代理承销证券款 | 0 | 0 | 0 | 0 |
一年内到期的非流动负债 | 1,424,471.43 | 1,930,666.04 | 2,033,899.69 | 2,000,698.89 |
其他流动负债 | 11,596,683.84 | 9,134,481.71 | 10,566,431.36 | 6,654,780.15 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 254,267,084.32 | 227,502,217.89 | 241,744,646.27 | 192,202,976.84 |
非流动负债: | ||||
长期借款 | 0 | 0 | 0 | 0 |
应付债券 | 0 | 0 | 0 | 0 |
优先股 | 0 | 0 | 0 | 0 |
永续债 | 0 | 0 | 0 | 0 |
租赁负债 | 0 | 0 | 504,437.04 | 912,241.95 |
长期应付款 | 0 | 0 | 0 | 0 |
长期应付职工薪酬 | 0 | 0 | 0 | 0 |
预计负债 | 0 | 0 | 0 | 0 |
递延收益 | 1,770,738.23 | 1,849,981.22 | 1,953,130.28 | 2,104,091.45 |
递延所得税负债 | 7,207.72 | 8,465.68 | 0 | 0 |
其他非流动负债 | 0 | 0 | 0 | 0 |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 1,777,945.95 | 1,858,446.9 | 2,457,567.32 | 3,016,333.4 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 256,045,030.27 | 229,360,664.79 | 244,202,213.59 | 195,219,310.24 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 225,204,580 | 225,204,580 | 225,204,580 | 225,204,580 |
其他权益工具 | 0 | 0 | 0 | 0 |
优先股 | 0 | 0 | 0 | 0 |
永续债 | 0 | 0 | 0 | 0 |
资本公积 | 804,702,166.32 | 804,702,166.32 | 804,702,166.32 | 804,702,166.32 |
减:库存股 | 27,001,109.25 | 27,001,109.25 | 27,001,109.25 | 1,409,056 |
其他综合收益 | -9,952,081.08 | -9,982,081.08 | -10,125,414.41 | -10,125,414.41 |
专项储备 | 0 | 0 | 0 | 0 |
盈余公积 | 113,844,980.85 | 113,844,980.85 | 113,844,980.85 | 113,844,980.85 |
一般风险准备 | 0 | 0 | 0 | 0 |
未分配利润 | 839,721,294.57 | 822,265,417.08 | 864,270,209.88 | 836,330,447.24 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 1,946,519,831.41 | 1,929,033,953.92 | 1,970,895,413.39 | 1,968,547,704 |
少数股东权益 | 15,837,399.91 | 16,072,822.76 | 16,276,538.36 | 16,675,817.77 |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 1,962,357,231.32 | 1,945,106,776.68 | 1,987,171,951.75 | 1,985,223,521.77 |
负债和股东权益合计 | 2,218,402,261.59 | 2,174,467,441.47 | 2,231,374,165.34 | 2,180,442,832.01 |
公告日期 | 2024-10-31 | 2024-08-28 | 2024-04-30 | 2024-04-30 |
审计意见(境内) | 标准无保留意见 |